Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Role of Mirnas in Covid-19 Disease Publisher



Fani M1 ; Zandi M2, 3 ; Ebrahimi S4 ; Soltani S2, 3 ; Abbasi S5
Authors

Source: Future Virology Published:2021


Abstract

Nowadays, the SARS Coronavirus 2 (SARS-CoV-2) infection is recognized as the primary cause of mortality in humans. SARS-CoV-2 is transmitted through human-to-human contact and is asymptomatic in most patients. In addition to approved vaccines against SARS-CoV-2 infection, miRNAs may also be promising options against this new virus. miRNAs are small and noncoding RNAs 18-25 nucleotides in length that target the mRNAs to degrade them or obstruct their translation miRNAs act as an observer in cells. This study reviewed the literature on the potential role of cellular miRNAs in the SARS-CoV-2-host interplay as a therapeutic option in COVID-19 patients. © 2021 Future Medicine Ltd.. All rights reserved.
Related Docs
View other Related Docs
1. Mirna Expression in Covid-19, Gene Reports (2022)
2. Cytokine Storm in the Pathophysiology of Covid-19: Possible Functional Disturbances of Mirnas, International Immunopharmacology (2021)
3. The Role of Viral and Host Mirnas in the Control, Progression and Possible Treatment of Covid-19 Disease, Journal of Payavard Salamat (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (1)
Reza Afrisham (1)
Other Related Docs
4. Evaluation of Microrna Expression Pattern (Mir-28, Mir-181A, Mir-34A, and Mir-31) in Patients With Covid-19 Admitted to Icu and Diabetic Covid-19 Patients, Intervirology (2023)
5. Dysregulated Mirnas Network in the Critical Covid-19: An Important Clue for Uncontrolled Immunothrombosis/Thromboinflammation, International Immunopharmacology (2022)
6. Hsa_Circ_0000479/Hsa-Mir-149-5P/Rig-I, Il-6 Axis: A Potential Novel Pathway to Regulate Immune Response Against Covid-19, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
7. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)
8. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)
9. Expression of Microrna-155 in Patients With Non-Hodgkin Lymphoma, Coronavirus Disease 2019, or Both: A Cross-Sectional Study, Iranian Journal of Medical Sciences (2023)
10. A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients, Biotechnology and Applied Biochemistry (2022)
11. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
12. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
13. Covid-19: Why Does Disease Severity Vary Among Individuals?, Respiratory Medicine (2021)
14. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
15. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
16. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
17. Evaluation of Mir-200C-3P and Mir-421-5P Levels During Immune Responses in the Admitted and Recovered Covid-19 Subjects, Infection# Genetics and Evolution (2022)
18. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
19. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
20. Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study, BMC Infectious Diseases (2024)